Skip to content

Uterine Rupture International Data Acquisition

Uterine Rupture in Pregnancy: the URIDA (Uterine Rupture International Data Acquisition) Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03576950
Acronym
URIDA
Enrollment
100
Registered
2018-07-05
Start date
2021-09-30
Completion date
2023-09-30
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Rupture Gravid

Keywords

Uterine rupture, Cesarean section, Labour, Myomectomy, Delivery

Brief summary

Uterine rupture represents an uncommon event: it is is a life-threatening obstetric complication with high maternal and perinatal morbidity and mortality. Indeed, uterine rupture may cause catastrophic maternal and fetal complications (uterine hemorrhage, hysterectomy with consequent fertility loss, maternal and fetal death or cerebral palsy) which are hardly acceptable within the context of a natural event such as birth. Uterine rupture can occur during pregnancy, early in labor or following a prolonged labor, most frequently near or at term and, rarely, during early to mid-pregnancy. Its prevalence ranges between 0.006% for women without previous cesarean section (CS) in the western countries, to 25% for women with obstructed labor in African countries. Pregnancy after myomectomy or CS, vaginal delivery after cesarean sections (VBACs) and vaginal delivery after myomectomy are potentially at risk of uterine rupture. Despite uterine rupture is widely considered a life-threatening condition, so far most of published data refer to case reports or very small case series. In this scenario, the Uterine Rupture International Data Acquisition study group would like to collect a large number of events, in order to identify the potential risk factors among different populations through a multivariate analysis.

Interventions

None listed

Sponsors

Università degli Studi dell'Insubria
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years

Inclusion criteria

* Women with uterine rupture occurred during pregnancy.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frameDescription
Uterine ruptureA retrospective analysis of 10 years.Women with uterine rupture occurred during pregnancy.

Secondary

MeasureTime frameDescription
ParityA retrospective analysis of 10 years.The number of previous delivery.
Body Mass IndexA retrospective analysis of 10 years.The Body Mass Index of each patient in which uterine rupture occurred.
Presence of myomasA retrospective analysis of 10 years.The occurrence of myomas in each patient in which uterine rupture occurred.
Gestational age at uterine ruptureA retrospective analysis of 10 years.Gestational age, calculated as weeks and days, in which uterine rupture occurred.
Hospital stayA retrospective analysis of 10 years.The hospital stay from the admission to the discharge, expressed in days.
Neonatal complicationsA retrospective analysis of 10 years.The occurrence of neonatal complications, included neonatal deaths.
HysterectomyA retrospective analysis of 10 years.The number of cases in which it was necessary to perform hysterectomy after uterine rupture.

Contacts

Primary ContactAndrea Tinelli, M.D.
andreatinelli@gmail.com+393392074078

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026